Marathon Trading Investment Management LLC Immuno Gen, Inc. Transaction History

Marathon Trading Investment Management LLC

  • $201 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$2.25 - $5.8 $101,250 - $261,000
-45,000 Closed
0 $0
Q3 2019

Nov 13, 2019
BUY
$2.22 - $3.39 $50,616 - $77,292
22,800 Added 102.7%
45,000 $109,000
Q2 2019

Aug 14, 2019
BUY
$1.8 - $3.3 $39,960 - $73,260
22,200 New
22,200 $48,000

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Marathon Trading Investment Management LLC Portfolio

Follow Marathon Trading Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email